[Results of the double-blind use of an alpha blockader, nicergoline, in cervico-prostatic dysfunctions].
A double-blind prospective trial investigated effects of Nicergoline on micturitional disorders in 60 selected patients with dysuria in the absence of prostate hypertrophy and neurologic disease. Results evaluated from 29 men treated with the product and 25 receiving placebo, taking into account functional improvement and urinary output variations, showed a statistically significant improvement in patients in the Nicergoline group.